News

Because certain IPF and post-transplant medications can cause sun sensitivity, skin protection is crucial, says columnist Sam Kirton.
A Texas researcher received a $219,000 NIH grant to study the potential of a treatment for radiation-induced pulmonary ...
Being diagnosed in January 2017 with idiopathic pulmonary fibrosis (IPF) and learning that the disease is chronic, progressive, and incurable was a lot for one day. Of course, I wanted a cure or ...
Over the coming months, the Pulmonary Fibrosis Foundation's 2025 PFF Walk will aim to raise more than $1 million for the ...
In total, 165 IPF patients with chronic cough were randomly assigned to one of three doses of nalbuphine ER (27, 54, or 108 mg) or a placebo, twice daily. The primary goal was to assess the therapy’s ...
Mice lacking let-7 in lung cells spontaneously develop lung injury, demonstrating that the tumor suppressor microRNA serves as a braking mechanism against the formation of profibrotic cells following ...
Nerandomilast (BI 1015550) is designed to block the activity of phosphodiesterase 4B (PDE4B), a pro-inflammatory enzyme involved in fibrosis. It’s expected to reduce inflammation and scarring in PF, ...
“Following productive FDA interactions and positive top-line results from the Phase 1b trial, we have designed our RENEW trial to test the promise of our dual mechanism approach to targeting alveolar ...
Developer to now seek orphan drug status for tranilast in US Orphan drug designation is granted by the European Commission to medications that target serious diseases affecting no more than 5 in ...
To find out, a research team led by Victor Thannickal, MD, senior study author and professor of medicine at Tulane, examined gene activity and protein production in lung tissues from IPF patients. The ...
In a previous column, I wrote about the challenges of losing weight, and that struggle only added to my unease when I had to transfer from the patient bed to the procedure table. The table was so thin ...